Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

Govaere, Olivier; Kragh Petersen, Sine; Martinez-Lopez, Nuria; Wouters, Jasper; Van Haele, Matthias; Mancina, Rosellina M.; Jamialahmadi, Oveis; Bilkei-Gorzo, Orsolya; Bel Lassen, Pierre; Darlay, Rebecca; Peltier, Julien; Palmer, Jeremy M.; Younes, Ramy; Tiniakos, Dina; Aithal, Guruprasad P.; Allison, Michael; Vacca, Michele; Göransson, Melker; Berlinguer-Palmini, Rolando; Clark, James E.; Drinnan, Michael J.; Yki-Järvinen, Hannele; Dufour, Jean-Francois; Ekstedt, Mattias; Francque, Sven; Petta, Salvatore; Bugianesi, Elisabetta; Schattenberg, Jörn M.; Day, Christopher P.; Cordell, Heather J.; Topal, Baki; Clément, Karine; Romeo, Stefano; Ratziu, Vlad; Roskams, Tania; Daly, Ann K.; Anstee, Quentin M.; Trost, Matthias; Härtlova, Anetta

Abstract

Background & Aims: Obesity-associated inflammation is a key player in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). However, the role of macrophage scavenger receptor 1 (MSR1, CD204) remains incompletely understood.

Methods: 170 NAFLD liver biopsies were processed for transcriptomic analysis and correlated with clinicopathological features. Msr1-/- and WT mice were submitted to a 16 week high-fat and high-cholesterol diet. Therapeutic intervention with monoclonal antibody against MSR1 was performed in mice and ex vivo human liver slices. Genetic susceptibility was assessed using GWAS data from 1,483 NAFLD patients and 430,101 participants of the UKBiobank.

Results: MSR1 expression was associated with the occurrence of hepatic lipid-laden foamy macrophages and correlated with the degree of steatosis and steatohepatitis in NAFLD patients. Mice lacking Msr1 were protected against diet-induced metabolic disorder, showing fewer hepatic foamy macrophages, less hepatic inflammation, improved dyslipidemia and glucose tolerance, while showing altered hepatic lipid metabolism. MSR1 induced a pro-inflammatory response via the JNK signalling pathway upon triggering by saturated fatty acids. In vitro blockade of the receptor prevented the accumulation of lipids in primary macrophages which inhibited the switch towards a pro-inflammatory phenotype and the release of cytokines such as TNF-ɑ. Targeting MSR1 using monoclonal antibody therapy in an obesity-associated NAFLD mouse model and human liver slices resulted in the prevention of foamy macrophage formation and inflammation. Moreover, we identified that rs41505344, a polymorphism in the upstream transcriptional region of MSR1, was associated with altered serum triglycerides and aspartate transaminase levels in a cohort of over 400,000 patients.

Conclusions: Taken together, our data suggest a critical role for MSR1 in lipid-induced inflammation and a potential therapeutic target for the treatment of NAFLD.

Citation

Govaere, O., Kragh Petersen, S., Martinez-Lopez, N., Wouters, J., Van Haele, M., Mancina, R. M., Jamialahmadi, O., Bilkei-Gorzo, O., Bel Lassen, P., Darlay, R., Peltier, J., Palmer, J. M., Younes, R., Tiniakos, D., Aithal, G. P., Allison, M., Vacca, M., Göransson, M., Berlinguer-Palmini, R., Clark, J. E., …Härtlova, A. (2022). Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. Journal of Hepatology, 76(5), 1001-1012. https://doi.org/10.1016/j.jhep.2021.12.012

• Journal Article Type: Article
• Acceptance Date: Dec 7, 2021
• Online Publication Date: Dec 21, 2021
• Publication Date: 2022-05
• Deposit Date: Dec 9, 2021
• Publicly Available Date: Dec 22, 2022
• Journal: Journal of Hepatology
• Print ISSN: 0168-8278
• Electronic ISSN: 1600-0641
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 76
• Issue: 5
• Pages: 1001-1012
• DOI: https://doi.org/10.1016/j.jhep.2021.12.012
• Keywords: macrophages, immunometabolism, NASH, inflammation
• Public URL: https://nottingham-repository.worktribe.com/output/6912556
• Publisher URL: https://www.sciencedirect.com/science/article/pii/S0168827821022546